In the article by Miura et al, 1 an error in the definition of DFS appeared on page 148.
‘A DFS event was defined as the length of time from primary treatment to recurrence or death’ should have been written as ‘A DFS event was defined as the length of time from primary treatment to recurrence’.
The authors apologise for this error.
REFERENCE
- 1. Miura Y, Hatakeyama S, Tanaka T, et al. Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer. BJUI Compass. 2022;3(2):146–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
